dexrazoxane has been researched along with Breast Neoplasms in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Li, H; Liu, K; Lu, C; Wang, Y; Yu, M; Zhang, P | 1 |
| Bozdag Kaplan, N; Kaplan, O | 1 |
| Aguirre, VJ; Barnett, D; Burdett, N; Joshi, R; Viana, FF | 1 |
| Catane, R; Cherny, N; Gabizon, A; Gips, M; Grenader, T; Heching, NI; Isacson, R; Mesika, L; Rosengarten, O; Segal, A; Tahover, E | 1 |
| Aryal, B; Baxa, U; Bonner, W; Cheng, G; Dickey, JS; Gonzalez, Y; Herman, E; Joseph, J; Kalyanaraman, B; Mason, KP; Mog, S; Nakamura, AJ; Parekh, P; Rao, VA; Redon, CE; Rosen, E; Shacter, E; Zielonka, J | 1 |
| Aigner, B; Arzberger, EJ; Bauernhofer, T; Niederkorn, A; Petru, E; Richtig, E | 1 |
| Geng, C; Li, X; Qi, X; Sun, F | 1 |
| Akabuogu, EU; Phyu, SM; Smith, TA | 1 |
| Geng, C; Shi, J; Sun, F | 1 |
1 review(s) available for dexrazoxane and Breast Neoplasms
| Article | Year |
|---|---|
Complete recovery of a wide local reaction by the use of dexrazoxane 72 hours after epirubicin extravasation: case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dexrazoxane; Dimethyl Sulfoxide; Drug Eruptions; Epirubicin; Extravasation of Diagnostic and Therapeutic Materials; Female; Fluorouracil; Free Radical Scavengers; Humans; Middle Aged; Time Factors; Topoisomerase II Inhibitors | 2014 |
3 trial(s) available for dexrazoxane and Breast Neoplasms
| Article | Year |
|---|---|
3D-STI evaluation of the effect of dexrazoxane on the mechanical properties of right ventricular myocardium in breast cancer patients treated with pirarubicin.
Topics: Biomarkers; Breast Neoplasms; Dexrazoxane; Doxorubicin; Humans; Myocardium; Sexually Transmitted Diseases; Stroke Volume; Ventricular Function, Left | 2020 |
Dexrazoxane protects breast cancer patients with diabetes from chemotherapy-induced cardiotoxicity.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cardiotonic Agents; Cardiotoxicity; Cyclophosphamide; Dexrazoxane; Diabetes Mellitus, Type 2; Drug Monitoring; Epirubicin; Female; Heart Function Tests; Humans; Middle Aged; Treatment Outcome | 2015 |
Dexrazoxane improves cardiac autonomic function in epirubicin-treated breast cancer patients with type 2 diabetes.
Topics: Antineoplastic Agents; Autonomic Nervous System; Breast Neoplasms; Dexrazoxane; Diabetes Mellitus, Type 2; Epirubicin; Female; Heart; Humans; Middle Aged; Prospective Studies | 2016 |
5 other study(ies) available for dexrazoxane and Breast Neoplasms
| Article | Year |
|---|---|
Evaluation of dexrazoxane effect on preventing acute cardiac arrhythmia in patients with breast cancer treated with neoadjuvant/adjuvant anthracycline-based chemotherapy.
Topics: Anthracyclines; Arrhythmias, Cardiac; Breast Neoplasms; Dexrazoxane; Female; Humans; Neoadjuvant Therapy; Retrospective Studies | 2021 |
Video-assisted thoracoscopy in the management of intrapleural extravasation of cytotoxic chemotherapy.
Topics: Breast Neoplasms; Combined Modality Therapy; Dexrazoxane; Doxorubicin; Extravasation of Diagnostic and Therapeutic Materials; Female; Humans; Iatrogenic Disease; Middle Aged; Thoracic Surgery, Video-Assisted; Thoracoscopy; Treatment Outcome | 2017 |
Dexrazoxane added to doxorubicin-based adjuvant chemotherapy of breast cancer: a retrospective cohort study with a comparative analysis of toxicity and survival.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cohort Studies; Cyclophosphamide; Dexrazoxane; Doxorubicin; Female; Humans; Middle Aged; Retrospective Studies; Survival Analysis | 2017 |
Mito-tempol and dexrazoxane exhibit cardioprotective and chemotherapeutic effects through specific protein oxidation and autophagy in a syngeneic breast tumor preclinical model.
Topics: Animals; Antioxidants; Autophagy; Breast Neoplasms; Cell Line, Tumor; Dexrazoxane; Disease Models, Animal; Female; Microtubule-Associated Proteins; Mitochondria, Heart; Organophosphorus Compounds; Oxidation-Reduction; Piperidines; Protein Carbonylation; Rats; Rats, Inbred SHR | 2013 |
Effects of Administered Cardioprotective Drugs on Treatment Response of Breast Cancer Cells.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carbazoles; Cardiomyopathies; Cardiotonic Agents; Cardiovascular Agents; Carvedilol; Cell Line, Tumor; Cell Survival; Dexrazoxane; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Enalapril; Female; Fluorodeoxyglucose F18; Humans; Metformin; Propanolamines; Radionuclide Imaging; Radiopharmaceuticals; Receptor, ErbB-2; Trastuzumab | 2016 |